MARCOS
GONZÁLEZ DÍAZ
Forscher in der Zeit 1993-2023
Instituto Argentino de Diagnóstico y Tratamiento
Buenos Aires, ArgentinaPublikationen in Zusammenarbeit mit Forschern von Instituto Argentino de Diagnóstico y Tratamiento (1)
2014
-
A randomized, open-label, multicentre, phase 2/3 study to evaluate the safety and efficacy of lumiliximab in combination with fludarabine, cyclophosphamide and rituximab versus fludarabine, cyclophosphamide and rituximab alone in subjects with relapsed chronic lymphocytic leukaemia
British Journal of Haematology, Vol. 167, Núm. 4, pp. 466-477